# US 2001/0024812 A1 · Methods and compositions for producing full length cDNA libraries

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2001/0024812 A1
- Document ID: US20010024812A1
- Status: Published application
- Kind: A1
- Application number: 09/799,645
- Filed: 2001-03-05
- Published: 2001-09-27
- Earliest claimed: 1999-07-13
- Assignees: Incyte Genomics, Inc.
- Inventors: Karl Guegler; Ruoying Tan; Michael J. Rose
- Web page: https://patentgrep.com/patent/US20010024812A1

## CPC

- C12N 15/1096: {cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

Methods and compositions are provided for producing full-length cDNA libraries. In the subject methods, full length first strand cDNAs are isolated using a fusion protein of an eIF-4E domain and an eIF-4G domain separated by a flexible linker. Also provided is the novel fusion protein employed in the subject methods, as well as nucleic acids encoding, and host cells capable of expressing, the same. Finally, kits for use in practicing the subject methods are provided. The subject invention finds use in a variety of applications in which full-length cDNA libraries are employed.

## Claims

### Claim 1

A method of isolating a nucleic acid having a 5′ end cap structure, said method comprising: contacting said nucleic acid with a fusion protein comprising an eIF-4E domain and an eIF-4G domain joined by a linker domain, whereby a complex of said fusion protein and nucleic acid is produced; and
isolating said complex.

### Claim 2 (depends on 1)

The method according to claim 1, wherein said nucleic acid is mRNA.

### Claim 3 (depends on 2)

The method according to claim 2, wherein said mRNA lacks a polyA+ tail.

### Claim 4 (depends on 1)

The method according to claim 1, wherein said nucleic acid is an mRNA/cDNA duplex.

### Claim 5 (depends on 1)

The method according to claim 1, wherein said fusion protein is stably associated with a solid support.

### Claim 6

A method for generating a cDNA library, said method comprising:
(a) generating a population of blunt-ended mRNA/cDNA duplexes;
(b) contacting said population of blunt-ended mRNA/cDNA duplexes with a fusion protein comprising an eIF-4E domain and an eIF-4G domain joined by a linker domain, to produce a reaction mixture including complexes of said fusion protein and blunt-ended mRNA/cDNA duplexes; and
(c) separating said complexes from the remainder of said reaction mixture.

### Claim 7 (depends on 6)

The method according to claim 6, wherein said population of blunt-ended mRNA/cDNA duplexes are generated by:
(a) contacting a population of mRNAs with a reverse transcriptase under conditions sufficient to produce a population of mRNA/cDNA duplexes; and
contacting said population of mRNA/cDNA duplexes with an RNAse under conditions sufficient to degrade single stranded RNA to produce a population of blunt-ended mRNA/cDNA duplexes.

### Claim 8 (depends on 6)

The method according to claim 6, wherein said fusion protein is stably associated with a solid support during said separating step.

### Claim 9

A method for generating a cDNA library, said method comprising:
(a) contacting a population of mRNAs with a reverse transcriptase under conditions sufficient to produce a population of mRNA/cDNA duplexes;
(b) contacting said population of mRNA/cDNA duplexes with an RNAse under conditions sufficient to degrade single stranded RNA to produce a population of blunt-ended mRNA/cDNA duplexes;
(c) contacting said population of blunt-ended mRNA/cDNA duplexes with a fusion protein comprising an eIF-4E domain and an eIF-4G domain joined by a linker domain, to produce complexes of said fusion protein and blunt-ended mRNA/cDNA duplexes in an aqueous mixture;
(d) separating said complexes from the remainder of said aqueous mixture; and
(e) disrupting said complexes to produce free blunt-ended mRNA/cDNA duplexes.

### Claim 10 (depends on 9)

The method according to claim 9, wherein said fusion protein of said complexes is stably associated with a solid support at least during said separating step.

### Claim 11

A fusion protein comprising an eIF-4E domain and a eIF-4G domain separated by a flexible linking domain.

### Claim 12 (depends on 11)

The fusion protein according to claim 11, wherein said protein has a binding affinity greater than eIF-4E for a 5′ cap structure of a nucleic acid.

### Claim 13 (depends on 11)

The fusion protein according to claim 11, wherein said protein further comprises a ligand domain.

### Claim 14 (depends on 11)

The fusion protein according to claim 11, wherein said protein is stably associated with a solid support.

### Claim 15 (depends on 11)

A nucleic acid encoding the fusion protein according to claim 11.

### Claim 16 (depends on 15)

A host cell comprising a nucleic acid according to claim 15.

### Claim 17

A kit for use in the preparation of a cDNA library, said kit comprising:
a fusion protein comprising an eIF-4E domain and a eIF-4G domain separated by a flexible linking domain.

### Claim 18 (depends on 17)

The kit according to claim 17, wherein said fusion protein is stably associated with a surface of a solid support.

### Claim 19 (depends on 17)

The kit according to claim 17, wherein said kit further comprises a reverse transcriptase.

### Claim 20 (depends on 17)

The kit according to claim 17, wherein said kit further comprises an RNAse.
